Molsidomine - Vectura
Alternative Names: CorunoLatest Information Update: 14 Jul 2016
At a glance
- Originator SkyePharma PLC
- Developer Therabel
- Class Heart failure therapies; Ischaemic heart disorder therapies; Morpholines; Small molecules; Sydnones; Vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Angina pectoris
Most Recent Events
- 20 Jan 2004 Launched for Angina pectoris in Belgium (PO)
- 17 Oct 2002 Registered for Angina pectoris in Belgium (PO)